Response to Letter to the Editor: High Oncotype DX Recurrence Score, Hereditary Cancer Syndromes, and Referral for Germline Genetic Testing.
Document Type
Response or Comment
Publication Date
12-19-2019
Journal
Clinical Breast Cancer
DOI
10.1016/j.clbc.2019.12.007
APA Citation
Casasanta, N., Amdur, R., & Kaltman, R. (2019). Response to Letter to the Editor: High Oncotype DX Recurrence Score, Hereditary Cancer Syndromes, and Referral for Germline Genetic Testing.. Clinical Breast Cancer, (). http://dx.doi.org/10.1016/j.clbc.2019.12.007
Peer Reviewed
1
Comments
Epub ahead of print